ArticleDiabetes care2024

Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.

David T Broome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.